Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Hua Guo |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants / Suresh Durgam en The Journal of Clinical Psychiatry, Año 2016 - Vol.77 - No.3 (Marzo)
[artículo]
Título : Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants : A randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder Tipo de documento: texto impreso Autores: Suresh Durgam, Autor ; Willie Earley, Autor ; Hua Guo, Autor Fecha de publicación: 2020 Artículo en la página: pp. 371–378 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Trastorno depresivo mayor - terapia farmacológica, Resistencia a los medicamentos, Terapia farmacológica, Piperazinas - efectos adversos. Resumen: Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy. Link: ./index.php?lvl=notice_display&id=21716
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.3 (Marzo) . - pp. 371–378[artículo] Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants : A randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder [texto impreso] / Suresh Durgam, Autor ; Willie Earley, Autor ; Hua Guo, Autor . - 2020 . - pp. 371–378.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2016 - Vol.77 - No.3 (Marzo) . - pp. 371–378
Palabras clave: Antidepresivos, Trastorno depresivo mayor - terapia farmacológica, Resistencia a los medicamentos, Terapia farmacológica, Piperazinas - efectos adversos. Resumen: Cariprazine is an atypical antipsychotic currently under investigation as adjunctive therapy in patients with major depressive disorder (MDD) who have inadequate response to standard antidepressant therapy. Link: ./index.php?lvl=notice_display&id=21716